PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

EHR care-complexity score tracks CLABSI risk in ICU adults

central line-associated bloodstream infectionCLABSIcentral venous catheterhealthcare-associated infectionelectronic health recordsMIMIC-IVeICUcritical careretrospective cohortinfection preventionantimicrobial stewardship Clinical Pharmacy Practice

Background Information

Higher care-exposure burden increases CLABSI risk in critical care.

Central line-associated bloodstream infections (CLABSIs) are significant concerns in intensive care units, impacting patient outcomes and healthcare costs. Patients with higher care-exposure burden scores had higher odds of developing adjudicated CLABSI or CLABSI-like bloodstream infection, with odds ratios up to 4.99 in the highest quartile. The score serves as a marker of cumulative care complexity for infection prevention but requires prospective validation before clinical use. Higher EHR-derived care-exposure burdens correlate with increased CLABSI risk, highlighting the need for infection-prevention strategies.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Li N, Huang J, Liu J, He Y

Citation: Li N, Huang J, Liu J, et al. Electronic health record-derived care-exposure burden and central line-associated bloodstream infection among critically ill adults: a multi-source retrospective cohort study. Frontiers in public health. 2026;14:1883942. doi:10.3389/fpubh.2026.1883942

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.